Altre lingue Chimeric Therapeutics Limited

Azioni

CHM

AU0000121576

Tempo differito Australian S.E. Altri mercati azionari 02:44:41 26/04/2024			Variaz. 5gg	Var. 1 gen.
0,029 ^AUD	0,00%		-6,45%	-17,14%

05/04	Chimeric Therapeutics ottiene la domanda di brevetto per la tecnologia CORE-NK; le azioni salgono del 3%.	MT
28/02	Chimeric Therapeutics Limited riporta i risultati degli utili per il semestre conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Chimeric Therapeutics Obtains Patent Application Covering CORE-NK Technology; Shares Up 3%	05/04
Chimeric Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Chimeric Therapeutics Treats First Patient in Phase 1B Leukemia Trial	08/02
Chimeric Therapeutics to Raise AU$3.2 Milion Via Shortfall Placement	18/01
Chimeric Therapeutics Opens Phase 1B Leukemia Trial	15/01
Chimeric Therapeutics Receives AU$7 Million R&D Tax Rebate for Fiscal Year 2023; Shares Rise 6%	10/01
Chimeric Therapeutics Secures AU$1 Million via Share Placement Deal	04/01
Chimeric Therapeutics Extends Closing Date of AU$10 Million Entitlement Offer	15/11
Chimeric Therapeutics Doses First Patient in Phase 1B Clinical Trial for Brain Cancer	02/11
Chimeric Therapeutics Announces FDA Clearance of IND Application for CHM 2101	31/10/23
Australian Shares Rebound Ahead of US Fed Policy Meeting	31/10/23
US FDA Gives Green Signal to Chimeric Therapeutics' IND Application for Gastrointestinal Cancer Drug; Shares Jump 65%	31/10/23
Chimeric Therapeutics to Raise AU$10 Million from Entitlement Offer	25/10/23
Chimeric Therapeutics Signs Deal to Support Leukemia Trial	13/09/23
Chimeric Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Chimeric Therapeutics Limited Announces Board Changes	30/08/23
Chimeric Therapeutics Limited Announces the Resignation of George Matcham as Non-Executive Director	03/08/23
Chimeric Therapeutics Secures Japanese Patent Allowance for Chlorotoxin	27/07/23
Chimeric Therapeutics Limited Announces Board Changes	12/07/23
Chimeric Therapeutics Secures Up to AU$12.6 Million for Clinical Trial, Therapy	23/06/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Chimeric Therapeutics Limited

Azioni

CHM

AU0000121576

Altre lingue

Filtri